MEIF Proof-of-Concept & Early Stage Fund
Venture capitalSeed–Series A
Find your way into MEIF Proof-of-Concept & Early Stage Fund
Sign up to see every warm intro you have to MEIF Proof-of-Concept & Early Stage Fund
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MEIF Proof-of-Concept & Early Stage Fund team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
What they invest in
from 1 of 1 portfolio companiesAI & Machine Learning ×1Biotech ×1Deep Tech ×1Medical Devices ×1
HQs:United Kingdom×1
Investments · 1 tracked
founders shown can be your intro pathTagomics develops multimodal technologies for precision medicine and next-generation diagnostics.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, GB
Dr Jack Kennefick(Co-founder, Director & Chief Executive Officer)Dr Robert Neely(Co-founder, Director & Chief Scientific Officer)
Co-investorsCalculus Capital Ltd.Illumina VenturesIQ CapitalStart CodonCalculusIllumina Innovation+3 more
Frequently asked questions
- What stage does MEIF Proof-of-Concept & Early Stage Fund invest at?
- MEIF Proof-of-Concept & Early Stage Fund invests at the Seed, Series A stages.
- What sectors does MEIF Proof-of-Concept & Early Stage Fund focus on?
- MEIF Proof-of-Concept & Early Stage Fund focuses on Biotech, IoT, SaaS.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Venrock is a venture capital firm investing across technology and healthcare, backing companies in fintech, developer infrastructure, life sciences, therapeutics, semiconductors, and consumer products.
Elm Street Ventures is a seed and early-stage venture fund in New Haven, Connecticut that primarily backs companies with a Yale connection, especially technology developed at and licensed from Yale.
Lauder Partners is the venture investment vehicle of Gary Lauder, investing in early- and growth-stage private companies across a broad range of technology, healthcare, energy and consumer sectors.
XAnge is a European early-stage venture capital firm, active for over two decades, backing ambitious founders building world-class technology assets in Europe.




.jpeg)



